Equities

Beijing Kawin Technology Share-Holding Co Ltd

688687:SHH

Beijing Kawin Technology Share-Holding Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)28.33
  • Today's Change-0.43 / -1.50%
  • Shares traded3.16m
  • 1 Year change-2.85%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,1731,2371,238
Total Receivables, Net444396387
Total Inventory140149144
Prepaid expenses191322
Other current assets, total46----
Total current assets1,8221,7951,791
Property, plant & equipment, net324184174
Goodwill, net------
Intangibles, net183158133
Long term investments685146
Note receivable - long term------
Other long term assets------
Total assets2,4482,2102,178
LIABILITIES
Accounts payable411366317
Accrued expenses424333
Notes payable/short-term debt80140
Current portion long-term debt/capital leases1.511.34--
Other current liabilities, total585563
Total current liabilities592479412
Total long term debt280.293.42
Total debt109163.42
Deferred income tax6.445.112.44
Minority interest316.238.90
Other liabilities, total374372
Total liabilities694534499
SHAREHOLDERS EQUITY
Common stock171171170
Additional paid-in capital1,2501,2441,247
Retained earnings (accumulated deficit)394311270
Treasury stock - common(60)(48)--
Unrealized gain (loss)(0.8)(2.68)--
Other equity, total0.070.11(7.74)
Total equity1,7541,6761,679
Total liabilities & shareholders' equity2,4482,2102,178
Total common shares outstanding167168170
Treasury shares - common primary issue3.513.040
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.